Filed: 11/14/2024ACC: 0001493152-24-045409
📋 What this filing means
RTW INVESTMENTS, LP filed this quarterly 13F‑HR report disclosing 68 equity positions with a total reported market value of $6.91B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
68
Positions
$6.91B
Total AUM (reported)
261.57M
Total Shares
Allocation by class
COM$5.48B79.3%
SPONSORED ADR$354.75M5.1%
SHS$324.56M4.7%
COM NEW$260.99M3.8%
COM PAR $.01$238.86M3.5%
ADS$151.60M2.2%
COM SHS$32.31M0.5%
Portfolio Concentration
Top 3$1.17B17.0%
4–10$2.01B29.1%
11–25$2.52B36.4%
Rest$1.21B17.5%
Top 3 weight
17.0%
Top 10 weight
46.1%
Voting Authority Distribution
Total shares with voting rights: 261.57M
Sole
Full voting authority
261.57M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole68
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings68
Rows:
MADRIGAL PHARMACEUTICALS INC
SOLEShares1.99M
TypeSH
Market value$423.10M
6.12%
Sole
1.99M
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
SOLEShares4.19M
TypeSH
Market value$376.52M
5.45%
Sole
4.19M
Shared
0.00
None
0.00
AVIDITY BIOSCIENCES INC
SOLEShares8.13M
TypeSH
Market value$373.54M
5.40%
Sole
8.13M
Shared
0.00
None
0.00
ARGENX SE
SOLEShares654.43K
TypeSH
Market value$354.75M
5.13%
Sole
654.43K
Shared
0.00
None
0.00
NATERA INC
SOLEShares2.59M
TypeSH
Market value$329.22M
4.76%
Sole
2.59M
Shared
0.00
None
0.00
ROCKET PHARMACEUTICALS INC
SOLEShares17.69M
TypeSH
Market value$326.69M
4.73%
Sole
17.69M
Shared
0.00
None
0.00
PTC THERAPEUTICS INC
SOLEShares7.39M
TypeSH
Market value$274.29M
3.97%
Sole
7.39M
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares6.82M
TypeSH
Market value$244.93M
3.54%
Sole
6.82M
Shared
0.00
None
0.00
PROTAGONIST THERAPEUTICS INC
SOLEShares5.43M
TypeSH
Market value$244.18M
3.53%
Sole
5.43M
Shared
0.00
None
0.00
BRUKER CORP
SOLEShares3.48M
TypeSH
Market value$240.41M
3.48%
Sole
3.48M
Shared
0.00
None
0.00
INSMED INC
SOLEShares3.27M
TypeSH
Market value$238.86M
3.46%
Sole
3.27M
Shared
0.00
None
0.00
ACADIA PHARMACEUTICALS INC
SOLEShares13.71M
TypeSH
Market value$210.82M
3.05%
Sole
13.71M
Shared
0.00
None
0.00
MERUS N V
SOLEShares4.17M
TypeSH
Market value$208.30M
3.01%
Sole
4.17M
Shared
0.00
None
0.00
GERON CORP
SOLEShares44.11M
TypeSH
Market value$200.27M
2.90%
Sole
44.11M
Shared
0.00
None
0.00
MASIMO CORP
SOLEShares1.46M
TypeSH
Market value$194.98M
2.82%
Sole
1.46M
Shared
0.00
None
0.00
ALKERMES PLC
SOLEShares6.65M
TypeSH
Market value$186.25M
2.69%
Sole
6.65M
Shared
0.00
None
0.00
AKERO THERAPEUTICS INC
SOLEShares5.92M
TypeSH
Market value$169.83M
2.46%
Sole
5.92M
Shared
0.00
None
0.00
APOGEE THERAPEUTICS INC
SOLEShares2.71M
TypeSH
Market value$159.31M
2.31%
Sole
2.71M
Shared
0.00
None
0.00
PENUMBRA INC
SOLEShares795.75K
TypeSH
Market value$154.62M
2.24%
Sole
795.75K
Shared
0.00
None
0.00
IMMUNOCORE HLDGS PLC
SOLEShares4.87M
TypeSH
Market value$151.60M
2.19%
Sole
4.87M
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares2.72M
TypeSH
Market value$143.68M
2.08%
Sole
2.72M
Shared
0.00
None
0.00
STRYKER CORPORATION
SOLEShares396.92K
TypeSH
Market value$143.39M
2.07%
Sole
396.92K
Shared
0.00
None
0.00
RADNET INC
SOLEShares1.81M
TypeSH
Market value$125.50M
1.82%
Sole
1.81M
Shared
0.00
None
0.00
ESTABLISHMENT LABS HLDGS INC
SOLEShares2.65M
TypeSH
Market value$114.48M
1.66%
Sole
2.65M
Shared
0.00
None
0.00
IMMATICS N.V
SOLEShares10M
TypeSH
Market value$114.10M
1.65%
Sole
10M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
MADRIGAL PHARMACEUTICALS INCSOLE | COM | 1.99M | SH | $423.10M 6.12% | 1.99M | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCSOLE | COM | 4.19M | SH | $376.52M 5.45% | 4.19M | 0.00 | 0.00 |
AVIDITY BIOSCIENCES INCSOLE | COM | 8.13M | SH | $373.54M 5.40% | 8.13M | 0.00 | 0.00 |
ARGENX SESOLE | SPONSORED ADR | 654.43K | SH | $354.75M 5.13% | 654.43K | 0.00 | 0.00 |
NATERA INCSOLE | COM | 2.59M | SH | $329.22M 4.76% | 2.59M | 0.00 | 0.00 |
ROCKET PHARMACEUTICALS INCSOLE | COM | 17.69M | SH | $326.69M 4.73% | 17.69M | 0.00 | 0.00 |
PTC THERAPEUTICS INCSOLE | COM | 7.39M | SH | $274.29M 3.97% | 7.39M | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 6.82M | SH | $244.93M 3.54% | 6.82M | 0.00 | 0.00 |
PROTAGONIST THERAPEUTICS INCSOLE | COM | 5.43M | SH | $244.18M 3.53% | 5.43M | 0.00 | 0.00 |
BRUKER CORPSOLE | COM | 3.48M | SH | $240.41M 3.48% | 3.48M | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 3.27M | SH | $238.86M 3.46% | 3.27M | 0.00 | 0.00 |
ACADIA PHARMACEUTICALS INCSOLE | COM | 13.71M | SH | $210.82M 3.05% | 13.71M | 0.00 | 0.00 |
MERUS N VSOLE | COM | 4.17M | SH | $208.30M 3.01% | 4.17M | 0.00 | 0.00 |
GERON CORPSOLE | COM | 44.11M | SH | $200.27M 2.90% | 44.11M | 0.00 | 0.00 |
MASIMO CORPSOLE | COM | 1.46M | SH | $194.98M 2.82% | 1.46M | 0.00 | 0.00 |
ALKERMES PLCSOLE | SHS | 6.65M | SH | $186.25M 2.69% | 6.65M | 0.00 | 0.00 |
AKERO THERAPEUTICS INCSOLE | COM | 5.92M | SH | $169.83M 2.46% | 5.92M | 0.00 | 0.00 |
APOGEE THERAPEUTICS INCSOLE | COM | 2.71M | SH | $159.31M 2.31% | 2.71M | 0.00 | 0.00 |
PENUMBRA INCSOLE | COM | 795.75K | SH | $154.62M 2.24% | 795.75K | 0.00 | 0.00 |
IMMUNOCORE HLDGS PLCSOLE | ADS | 4.87M | SH | $151.60M 2.19% | 4.87M | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 2.72M | SH | $143.68M 2.08% | 2.72M | 0.00 | 0.00 |
STRYKER CORPORATIONSOLE | COM | 396.92K | SH | $143.39M 2.07% | 396.92K | 0.00 | 0.00 |
RADNET INCSOLE | COM | 1.81M | SH | $125.50M 1.82% | 1.81M | 0.00 | 0.00 |
ESTABLISHMENT LABS HLDGS INCSOLE | COM | 2.65M | SH | $114.48M 1.66% | 2.65M | 0.00 | 0.00 |
IMMATICS N.VSOLE | SHS | 10M | SH | $114.10M 1.65% | 10M | 0.00 | 0.00 |
Page 1 of 3